ストックスクリーナーアプリを入手
43.67
2.59%
1.0128
前日終値:
$42.66
開ける：
$43.16
24時間の取引高:
67,836
Relative Volume:
0.07
時価総額：
$2.72B
収益：
-
当期純損益:
$-229.97M
株価収益率:
-10.10
EPS:
-4.3234
ネットキャッシュフロー:
$-136.51M
1週間 パフォーマンス:
+0.22%
1か月 パフォーマンス:
+12.22%
6か月 パフォーマンス:
+158.96%
1年 パフォーマンス:
+1,052%
1日の値動き範囲:
$42.10
$43.86
1週間の範囲:
$41.89
$46.59
52週間の値動き範囲:
$2.8101
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
43.81 | 2.65B | 0 | -229.97M | -136.51M | -4.3234 |
VRTX
Vertex Pharmaceuticals Inc
|
425.05 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
717.96 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.41 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.06 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.50 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-11 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-09-25 | アップグレード | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 開始されました | Jefferies | Buy |
| 2025-08-14 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-12-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-05 | 開始されました | H.C. Wainwright | Neutral |
| 2023-12-11 | 再開されました | Goldman | Sell |
| 2023-11-17 | アップグレード | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-07-25 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-07-24 | ダウングレード | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2022-11-15 | 開始されました | CapitalOne | Overweight |
| 2022-08-02 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-02-24 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2022-02-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 開始されました | Evercore ISI | Outperform |
| 2021-03-01 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2021-02-17 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2021-01-25 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-12-11 | 開始されました | Citigroup | Neutral |
| 2020-11-30 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-11-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-31 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-03 | 開始されました | Goldman | Buy |
| 2020-02-18 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 開始されました | SunTrust | Buy |
| 2020-01-08 | 開始されました | ROTH Capital | Buy |
| 2020-01-03 | 開始されました | Jefferies | Buy |
| 2019-12-24 | 開始されました | JP Morgan | Overweight |
| 2019-10-15 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-02-20 | 開始されました | Chardan Capital Markets | Buy |
| 2018-10-29 | 開始されました | Barclays | Overweight |
| 2018-10-29 | 開始されました | BofA/Merrill | Buy |
| 2018-10-29 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Kodiak Sciences Inc (KOD) 最新ニュース
Kodiak Sciences stock is surging Friday: What's driving the action? - MSN
Kodiak Sciences (KOD) up 2% since last earnings report: Can it continue? - MSN
Kodiak Sciences Inc. $KOD Stock Holdings Decreased by RIA Advisory Group LLC - MarketBeat
Eye drug data from Taiwan cohort backs Kodiak Phase 3 expansion - Stock Titan
Kodiak Sciences Presents Pipeline Advances and KSI-101 Clinical Data At Scientific Conferences - marketscreener.com
Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
US stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage study - MSN
Kodiak Q4 loss wider than expected, pipeline development in focus - MSN
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares - Quantisnow
Diabetic Retinopathy Pipeline Set for Transformational Breakthroughs by 2026 with 55+ Therapies expanding Clinical Innovation from Kodiak Sciences, Regenxbio, Adverum Biotechnologies | DelveInsight - Barchart
Diabetic Retinopathy Pipeline Set for Transformational - openPR.com
BlackRock (KOD) holds 3.27M shares, a 5.3% stake in Kodiak Sciences (KOD) - Stock Titan
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy - MSN
Kodiak Sciences Reports Positive Trial Results for Diabetic Retinopathy - HarianBasis.co
Kodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda? - Insider Monkey
KOD Kodiak Sciences Inc reports narrow Q4 2025 EPS beat, shares drop 3.74 percent on weak investor sentiment.Viral Trade Signals - Xã Thanh Hà
[ARS] Kodiak Sciences Inc. SEC Filing - Stock Titan
Executive pay and 2026 director vote at Kodiak Sciences (NASDAQ: KOD) - Stock Titan
Is Kodiak Sciences (KOD) stock stronger than industry leaders (-1.28%) 2026-04-22Diversification - Cổng thông tin điện tử tỉnh Lào Cai
10 Best 52-Week High US Stocks to Buy - Insider Monkey
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Kodiak Sciences Stock Is On The Move - TipRanks
Kodiak Sciences Inc stock hits 52-week high at $46.69 By Investing.com - Investing.com Australia
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month HighWhat's Next? - MarketBeat
Kodiak Sciences Inc stock hits 52-week high at $46.69 - Investing.com
Kodiak Sciences (KOD) reports Q4 EPS of ($1.05) - MSN
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8%What's Next? - MarketBeat
Kodiak Sciences KOD Stock Soars On Phase 3 Win - timothysykes.com
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers - Benzinga
Kodiak Sciences (NASDAQ: KOD) CFO exercises options, now holds 211,930 shares - Stock Titan
Kodiak Sciences (NASDAQ:KOD) Signals Behind Surge Points To Momentum - Kalkine Media
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 39.8% in March - MarketBeat
Kodiak Sciences (KOD) Stock: Downtrend Signals? (Loses Ground) 2026-04-15Overvalued Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Stock Price Drops 5.5% - National Today
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.5%Should You Sell? - MarketBeat
Kodiak Sciences shares jump on encouraging Phase 3 trial results - MSN
Why Kodiak Sciences Stock Is Surging Higher Today - TipRanks
Kodiak Sciences (KOD) climbs 75% on stellar clinical results - MSN
Kodiak Sciences Inc (KOD) 財務データ
収益
当期純利益
現金流量
EPS
Kodiak Sciences Inc (KOD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | Chief Financial Officer |
Apr 02 '26 |
Option Exercise |
1.04 |
30,000 |
31,200 |
213,316 |
| BORGESON JOHN A. | Chief Financial Officer |
Apr 02 '26 |
Sale |
39.92 |
30,000 |
1,197,488 |
183,316 |
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):